Bay Street News, 2020

BASKING RIDGE, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) — Hans Vestberg, Chairman and CEO for Verizon, is scheduled to speak […]

Alzheimer’s Patients in Drug Groups Showed Statistically Significant Improvements in Biomarkers of Disease Compared to Placebo Group (P<0.05)Alzheimer’s Patients in […]

MATTOON, Ill., Sept. 14, 2020 (GLOBE NEWSWIRE) — Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) (“Consolidated”) announced today that its wholly-owned […]

CAMBRIDGE, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new […]

OTTAWA, Sept. 14, 2020 (GLOBE NEWSWIRE) — Leonovus Inc., (“Leonovus” or the “Company”) (TSXV: LTV) further to its news release of […]

CALGARY, Alberta, Sept. 14, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “Flyht”) […]

LEXINGTON, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]

All dose groups achieved statistically significant reductions in liver fat, with relative reductions of up to 60% versus baseline and […]

LA JOLLA, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company […]

ORLANDO, FL, Sept. 14, 2020 (GLOBE NEWSWIRE) — Coda Octopus Group, Inc. (CODA) (Nasdaq: CODA) today reported its unaudited financial […]